Advanced Oncotherapy plc

Advanced Oncotherapy plcverified

AVO.L

Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

Industry

Medical - Devices

IPO Date

2006-08-04

Stock Exchange

LSE

Ticker

AVO.L

The PE Ratio as of November 2025 (TTM) for Advanced Oncotherapy plc (AVO.L) is -0.25

According to Advanced Oncotherapy plc’s latest financial reports and current stock price. The company's current PE Ratio is -0.25. This represents a change of 1.75% compared to the average of -0.01 of the last 4 quarters.

Advanced Oncotherapy plc (AVO.L) Historical PE Ratio (quarterly & annually)

How has AVO.L PE Ratio performed in the past?

The mean historical PE Ratio of Advanced Oncotherapy plc over the last ten years is -0.05. The current -0.25 PE Ratio has changed 53.63% with respect to the historical average. Over the past ten years (40 quarters), AVO.L's PE Ratio was at its highest in in the June 2006 quarter at 0.18. The PE Ratio was at its lowest in in the December 2015 quarter at -145.11.

Quarterly (TTM)
Annual

Average

-0.05

Median

-0.04

Minimum

-0.16

Maximum

-0.01

Advanced Oncotherapy plc (AVO.L) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Advanced Oncotherapy plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 433.56%

Maximum Annual PE Ratio = -0.01

Minimum Annual Increase = -72.00%

Minimum Annual PE Ratio = -0.16

Quarterly (TTM)
Annual
YearPE RatioChange
2021-0.0420.22%
2020-0.03-15.69%
2019-0.0444.39%
2018-0.03-16.19%
2017-0.03-24.23%
2016-0.04-72.00%
2015-0.16248.42%
2014-0.0538.18%
2013-0.03433.56%
2012-0.01131.87%

Advanced Oncotherapy plc (AVO.L) Average PE Ratio

How has AVO.L PE Ratio performed in the past?

The current PE Ratio of Advanced Oncotherapy plc (AVO.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-0.04

5-year avg

-0.04

10-year avg

-0.05

Advanced Oncotherapy plc (AVO.L) PE Ratio vs. Peers

How is AVO.L’s PE Ratio compared to its peers?

Advanced Oncotherapy plc’s PE Ratio is less than MGC Pharmaceuticals Limited (-0.06), greater than Induction Healthcare Group PLC (-2.78), greater than Celadon Pharmaceuticals Plc (-1.16), greater than BiVictriX Therapeutics Plc (-2.85), less than Synairgen plc (-0.23), less than Belluscura plc (-0.07), greater than Argent BioPharma Limited (-0.25), greater than NetScientific plc (-4.66), less than Kanabo Group Plc (-0.15), greater than Cel AI PLC (-0.56),

Build a custom stock screener for Advanced Oncotherapy plc (AVO.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Advanced Oncotherapy plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Advanced Oncotherapy plc (AVO.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Advanced Oncotherapy plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Advanced Oncotherapy plc's PE Ratio?

How is the PE Ratio calculated for Advanced Oncotherapy plc (AVO.L)?

What is the highest PE Ratio for Advanced Oncotherapy plc (AVO.L)?

What is the 3-year average PE Ratio for Advanced Oncotherapy plc (AVO.L)?

What is the 5-year average PE Ratio for Advanced Oncotherapy plc (AVO.L)?

How does the current PE Ratio for Advanced Oncotherapy plc (AVO.L) compare to its historical average?